[1] |
Ying L, Zhang Y, Yin J, et al. Classic type 1 diabetes mellitus and fulminant type 1 diabetes mellitus: similarity and discrepancy of immunological characteristics and cytokine profile[J]. Diabetes Metab Syndr Obes, 2021, 14: 4661-4670.
doi: 10.2147/DMSO.S334712
|
[2] |
Qiu J, Li X, Chen W, et al. The fulminant index: a method of rapidly differentiating fulminant type 1 diabetes from diabetic ketoacidosis[J]. Diabetes Metab Res Rev, 2022, 38(3): e3501.
|
[3] |
谢新荣, 钟慕贤, 黄普好. 新发暴发性1型糖尿病与经典1型糖尿病及成人隐匿性自身免疫性糖尿病的临床特征比较[J]. 中国糖尿病杂志, 2021, 29(10): 754-757.
|
[4] |
卿松, 吴瑾, 袁传杰, 等. 儿童糖尿病酮症酸中毒临床诊治分析[J]. 中华妇幼临床医学杂志(电子版), 2018, 14(6): 724-729.
|
[5] |
Imagawa A, Hanafusa T, Awata T, et al. Report of the committee of the Japan diabetes society on the research of fulminant and acute-onset type 1 diabetes mellitus: new diagnostic criteria of fulminant type 1 diabetes mellitus (2012)[J]. J Diabetes Investig, 2012, 3(6): 536-539.
doi: 10.1111/jdi.12024
|
[6] |
American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022[J]. Diabetes Care, 2022, 45(Suppl 1): S17-S38.
doi: 10.2337/dc22-S002
|
[7] |
Acerini C, Craig ME, de Beaufort C, et al. Introduction to ISPAD clinical practice consensus guidelines 2014 compendium[J]. Pediatr Diabetes, 2014, 15 (Suppl 20): 1-3.
|
[8] |
中华医学会儿科学分会内分泌遗传代谢学组, 中华儿科杂志编辑委员会. 中国儿童1型糖尿病标准化诊断与治疗专家共识(2020版)[J]. 中华儿科杂志, 2020, 58 (6): 447-454.
|
[9] |
Goldstein B, Giroir B, Randolph A. International consensus conference on pediatric sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics[J]. Pediatr Crit Care Med, 2005, 6(1): 2-8.
doi: 10.1097/01.PCC.0000149131.72248.E6
|
[10] |
Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents[J]. Pediatrics, 2017, 140(3): e20171904.
|
[11] |
Imagawa A, Hanafusa T, Uchigata Y, et al. Fulminant type 1 diabetes: a nationwide survey in Japan[J]. Diabetes Care, 2003, 26(8): 2345-2352.
doi: 10.2337/diacare.26.8.2345
pmid: 12882860
|
[12] |
Cho YM, Kim JT, Ko KS, et al. Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes[J]. Diabetologia, 2007, 50(11): 2276-2279.
doi: 10.1007/s00125-007-0812-z
pmid: 17724575
|
[13] |
Luo S, Zhang Z, Li X, et al. Fulminant type 1 diabetes: a collaborative clinical cases investigation in China[J]. Acta Diabetol, 2013, 50(1): 53-59.
doi: 10.1007/s00592-011-0362-1
pmid: 22193926
|
[14] |
Imagawa A, Hanafusa T, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM study group[J]. N Engl J Med, 2000, 342(5): 301-307.
doi: 10.1056/NEJM200002033420501
|
[15] |
Imagawa A, Hanafusa T. Series: clinical study from Japan and its reflections; a nationwide survey of fulminant type 1 diabetes[J]. Nihon Naika Gakkai Zasshi, 2013, 102(7): 1829-1835.
doi: 10.2169/naika.102.1829
|
[16] |
Imagawa A, Hanafusa T, Iwahashi H, et al. Uniformity in clinical and HLA-DR status regardless of age and gender within fulminant type 1 diabetes[J]. Diabetes Res Clin Pract, 2008, 82(2): 233-237.
doi: 10.1016/j.diabres.2008.08.003
|
[17] |
Baden MY, Imagawa A, Abiru N, et al. Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapy[J]. Diabetol Int, 2018, 10(1): 58-66.
doi: 10.1007/s13340-018-0362-2
|
[18] |
王蓉蓉, 宫雯雯. 1例PD-1抑制剂相关暴发性1型糖尿病病例报道及文献复习[J]. 中国药物应用与监测, 2022, 19(1): 58-60.
|
[19] |
Huang X, Yang M, Wang L, et al. Sintilimab induced diabetic ketoacidosis in a patient with small cell lung cancer: a case report and literature review[J]. Medicine (Baltimore), 2021, 100(19): e25795.
|
[20] |
Imagawa A, Hanafusa T, Uchigata Y, et al. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus[J]. Diabetologia, 2005, 48(2): 294-300.
doi: 10.1007/s00125-004-1626-x
pmid: 15688210
|
[21] |
Kawabata Y, Ikegami H. Genetics of fulminant type 1 diabetes[J]. Diabetol Int, 2020, 11(4): 315-322.
doi: 10.1007/s13340-020-00468-0
|
[22] |
王毅, 巩纯秀, 曹冰燕, 等. 探讨儿童及青少年暴发性1型糖尿病分型的临床意义[J]. 中华糖尿病杂志, 2014, 6(10): 721-724.
|
[23] |
郑超, 王臻, 张贻宇, 等. 暴发性1型糖尿病临床流行病学调查[J]. 中国糖尿病杂志, 2009, 17(9): 646-648.
|
[24] |
Gu Y, Wang Y, Li P, et al. Fulminant type 1 diabetes in children: a multicenter study in China[J]. J Diabetes Res, 2017, 2017: 6924637.
|
[25] |
Sayama K, Imagawa A, Okita K, et al. Pancreatic beta and alpha cells are both decreased in patients with fulminant type 1 diabetes: a morphometrical assessment[J]. Diabetologia, 2005, 48(8): 1560-1564.
doi: 10.1007/s00125-005-1829-9
pmid: 15991022
|
[26] |
Song SO, Yun JS, Ko SH, et al. Prevalence and clinical characteristics of fulminant type 1 diabetes mellitus in Korean adults: a multi-institutional joint research[J]. J Diabetes Investig, 2022, 13(1): 47-53.
doi: 10.1111/jdi.v13.1
|
[27] |
柳岚, 曾玲, 桑丹, 等. 暴发性1型糖尿病研究新进展[J]. 中国糖尿病杂志, 2018, 26(5): 431-436.
|
[28] |
Yagihashi S. Diabetes and pancreas size, does it matter?[J]. J Diabetes Investig, 2017, 8(4): 413-415.
doi: 10.1111/jdi.2017.8.issue-4
|
[29] |
Luo S, Ma X, Li X, et al. Fulminant type 1 diabetes: a comprehensive review of an autoimmune condition[J]. Diabetes Metab Res Rev, 2020, 36(6): e3317.
|
[30] |
Liu L, Jia W, Wu Y, et al. Plasma glucose to glycated hemoglobin ratio: Method of differentiating fulminant type 1 diabetes from diabetic ketoacidosis[J]. Ann Endocrinol (Paris), 2019, 80(1): 16-20.
doi: S0003-4266(18)30024-6
pmid: 29731109
|
[31] |
Takahashi N, Tsujimoto T, Chujo D, et al. High risk of renal dysfunction in patients with fulminant type 1 diabetes[J]. J Diabetes Investig, 2018, 9(1): 146-151.
doi: 10.1111/jdi.2018.9.issue-1
|
[32] |
Yang D, Zhou Y, Luo S, et al. Clinical characteristics of fulminant type 1 diabetes compared with typical type 1 diabetes: one-year follow-up study from the Guangdong T1DM translational medicine study[J]. J Diabetes Res, 2020, 2020: 8726268.
|
[33] |
Kent LA, Gill GV, Williams G. Mortality and outcome of patients with brittle diabetes and recurrent ketoacidosis[J]. Lancet, 1994, 344(8925): 778-781.
pmid: 7916072
|